- Filed
- Feb 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 30, 2025 | 91.31M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 94.77M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 98.09M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 120.06M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 120.1M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2024 | $189.75M |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $0 |
| Capex | Q2 2025 · Dec 31, 2024 | $39.88M |
| Capex | Q2 2025 · Dec 31, 2023 | $49.07M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2024 | $179.32M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $35.38M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $0 |
| Long Term Debt | Q2 2025 · Jun 30, 2024 | $0 |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $150.99M |
| Short Term Debt | Q2 2025 · Jun 30, 2024 | $102.53M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $85.85M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $125.15M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $732.65M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $746.56M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $1.42B |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $1.44B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $608.41M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $755.26M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $3.14B |
| Total Assets | Q2 2025 · Jun 30, 2024 | $3.4B |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$1.01 |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$0.26 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.45 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.82 |
| Eps Basic | Q2 2025 · Dec 31, 2024 | −$1.01 |
| Eps Basic | Q2 2025 · Dec 31, 2024 | −$0.26 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.45 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.83 |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $253.77M |
| Sga Expense | Q2 2025 · Dec 31, 2024 | $388.65M |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $137.66M |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $270.8M |
| Rd Expense | Q2 2025 · Dec 31, 2024 | $726K |
| Rd Expense | Q2 2025 · Dec 31, 2024 | $1.31M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $928K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $1.79M |
| Operating Income | Q2 2025 · Dec 31, 2024 | −$92.82M |
| Operating Income | Q2 2025 · Dec 31, 2024 | −$57.51M |
| Operating Income restated | Q2 2025 · Dec 31, 2023 | $62.9M |
| Operating Income restated | Q2 2025 · Dec 31, 2023 | $121.24M |
| Gross Profit | Q2 2025 · Dec 31, 2024 | $171.21M |
| Gross Profit | Q2 2025 · Dec 31, 2024 | $351.63M |
| Gross Profit restated | Q2 2025 · Dec 31, 2023 | $213.88M |
| Gross Profit restated | Q2 2025 · Dec 31, 2023 | $418.78M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | $69.06M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | $136.78M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | $65.99M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | $130.12M |
| Revenue | Q2 2025 · Dec 31, 2024 | $240.27M |
| Revenue | Q2 2025 · Dec 31, 2024 | $488.41M |
| Revenue restated | Q2 2025 · Dec 31, 2023 | $279.87M |
| Revenue restated | Q2 2025 · Dec 31, 2023 | $548.9M |